Poster Presentation Skin Cancer 2024

What can other nations learn from the Australian Sunsmart story? (#175)

Bronwen McNoe 1 , Ryan Gage 2 , Louise Signal 2
  1. University of Otago, Dunedin, New Zealand
  2. University of Otago, Wellington, New Zealand

Background: Australia has demonstrated superior progress in the primary prevention of skin cancer compared to other countries worldwide. For instance, Aotearoa New Zealand (A/NZ) shares similarly high rates of skin cancer but has limited investment in primary prevention initiatives. This prompts the question of how A/NZ and other nations can apply the lessons learned in Australia to their own jurisdictions.

Methods: This presentation will detail a project that explored the perspectives of stakeholders in Australia on successful strategies for skin cancer primary prevention that may be transferrable to other countries. Through in-depth interviews with experts engaged in skin cancer prevention advocacy and action in Australia, we identified key facilitators and barriers. Additionally, a comparative analysis of the context in A/NZ was considered.

Results: Australia's comprehensive Sunsmart program exemplifies successful skin cancer prevention initiatives. Key strategies identified included strong leadership, supportive legislation (e.g., banning solaria), coalition-building among advocates, and strategic media campaigns. These strategies have played a crucial role in achieving reductions in skin cancer incidence and mortality rates in Australia particularly in younger age groups that have experienced Sunsmart from the start of their lives. One particular strategy on occupational UVR exposure shows promise in A/NZ and this will be discussed.

Conclusions: The findings of this study highlight the importance of adopting evidence-based strategies and fostering collaborative approaches in skin cancer prevention advocacy. While Australia's success serves as a valuable model, it is essential for other nations to adapt these strategies to their unique contexts to effectively combat skin cancer.